AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis
- PMID: 32359562
- PMCID: PMC9473154
- DOI: 10.1053/j.gastro.2020.02.038
AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis
Comment in
-
Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis-new data bring new questions.Aliment Pharmacol Ther. 2023 May;57(10):1161-1162. doi: 10.1111/apt.17442. Aliment Pharmacol Ther. 2023. PMID: 37094308 No abstract available.
References
-
- Sultan S, Falck-Ytter Y, Inadomi JM. The AGA Institute process for developing clinical practice guidelines part one: grading the evidence. Clin Gastroenterol Hepatol. 2013;11:329–332. - PubMed
-
- Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. In: Graham R, Mancher M, et al., eds. Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Press; 2011. - PubMed
-
- Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous